ACTIVITY OF THE CEDIRANIB IN ASPS (from CTOS 2008 meeting)
Posted: Sat Oct 04, 2008 9:59 pm
There is an ASPS related presentation on CTOS 14th Annual Meeting (November 13–15, 2008, London United Kingdom),
On Saturday, November 15, 2008
(34936) ACTIVITY OF THE VEGFR/KIT TYROSINE KINASE INHIBITOR CEDIRANIB (AZD2171) IN ALVEOLAR SOFT PART SARCOMA.
by Ian Judson's team from Royal Marsden Hospital , London, , United Kingdom and Astra Zeneca, Macclesfield, , United Kingdom.
This is the result of the trial of cediranib that our member Paul was on and pointed to us its activity. It will be interesting to know how other ASPS patients responded to it. I hope that we will be able to obtain the text of the article or at least an abstract will be published on the ASCO web-site later on.
On Saturday, November 15, 2008
(34936) ACTIVITY OF THE VEGFR/KIT TYROSINE KINASE INHIBITOR CEDIRANIB (AZD2171) IN ALVEOLAR SOFT PART SARCOMA.
by Ian Judson's team from Royal Marsden Hospital , London, , United Kingdom and Astra Zeneca, Macclesfield, , United Kingdom.
This is the result of the trial of cediranib that our member Paul was on and pointed to us its activity. It will be interesting to know how other ASPS patients responded to it. I hope that we will be able to obtain the text of the article or at least an abstract will be published on the ASCO web-site later on.